Mutay Aslan

4.9k total citations
134 papers, 3.7k citations indexed

About

Mutay Aslan is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mutay Aslan has authored 134 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 31 papers in Physiology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mutay Aslan's work include Sphingolipid Metabolism and Signaling (15 papers), Nitric Oxide and Endothelin Effects (13 papers) and Hemoglobinopathies and Related Disorders (11 papers). Mutay Aslan is often cited by papers focused on Sphingolipid Metabolism and Signaling (15 papers), Nitric Oxide and Endothelin Effects (13 papers) and Hemoglobinopathies and Related Disorders (11 papers). Mutay Aslan collaborates with scholars based in Türkiye, United States and Germany. Mutay Aslan's co-authors include Bruce Α. Freeman, Tomris Özben, Ayşel Ağar, Narin Derin, Ayşegül Çört, Filiz Özcan, İclal Yücel, Dale A. Parks, Serdar Doğan and Piraye Yargıçoğlu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Mutay Aslan

130 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mutay Aslan Türkiye 32 1.3k 774 613 390 357 134 3.7k
Toshiaki Tamaki Japan 41 1.8k 1.4× 1.2k 1.5× 280 0.5× 352 0.9× 382 1.1× 201 5.1k
Neelam Khaper Canada 34 1.7k 1.3× 761 1.0× 246 0.4× 650 1.7× 210 0.6× 86 4.7k
Georg Kojda Germany 32 1.1k 0.8× 2.1k 2.7× 817 1.3× 481 1.2× 256 0.7× 108 4.8k
Jung H. Suh United States 30 1.3k 1.0× 579 0.7× 192 0.3× 613 1.6× 185 0.5× 59 2.9k
Paula Grammas United States 45 2.1k 1.6× 1.9k 2.5× 214 0.3× 198 0.5× 340 1.0× 140 6.2k
Lucia Ciccoli Italy 37 1.4k 1.0× 667 0.9× 133 0.2× 180 0.5× 163 0.5× 100 3.7k
Anna Nicolaou United Kingdom 43 1.7k 1.3× 680 0.9× 282 0.5× 765 2.0× 105 0.3× 144 5.1k
Cláudia Penna Italy 45 1.9k 1.4× 986 1.3× 188 0.3× 323 0.8× 64 0.2× 167 5.5k
Seong‐Ho Koh South Korea 36 2.1k 1.6× 1.3k 1.6× 660 1.1× 101 0.3× 86 0.2× 166 5.5k
Jędrzej Antosiewicz Poland 30 1.1k 0.8× 551 0.7× 145 0.2× 117 0.3× 208 0.6× 123 2.8k

Countries citing papers authored by Mutay Aslan

Since Specialization
Citations

This map shows the geographic impact of Mutay Aslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutay Aslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutay Aslan more than expected).

Fields of papers citing papers by Mutay Aslan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mutay Aslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutay Aslan. The network helps show where Mutay Aslan may publish in the future.

Co-authorship network of co-authors of Mutay Aslan

This figure shows the co-authorship network connecting the top 25 collaborators of Mutay Aslan. A scholar is included among the top collaborators of Mutay Aslan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mutay Aslan. Mutay Aslan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Aslan, Mutay, et al.. (2025). NLRP3 inflammasome inhibition by MCC950 reduces embryo implantation during early pregnancy in mice. Immunopharmacology and Immunotoxicology. 47(6). 751–763. 1 indexed citations
4.
Derin, Narin, et al.. (2024). Chronic Nasal Administration of Kisspeptin-54 Regulates Mood-Related Disorders Via Amygdaloid GABA in Hemi-Parkinsonian Rats. Balkan Medical Journal. 41(6). 476–483. 2 indexed citations
5.
Aslan, Mutay, et al.. (2024). Sparstolonin B Reduces Estrogen-Dependent Proliferation in Cancer Cells: Possible Role of Ceramide and PI3K/AKT/mTOR Inhibition. Pharmaceuticals. 17(12). 1564–1564. 1 indexed citations
6.
7.
Aslan, İbrahim, et al.. (2023). Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients. Prostaglandins & Other Lipid Mediators. 166. 106719–106719. 3 indexed citations
8.
Özkan, Ayşe, Mehmet Bülbül, Narin Derin, et al.. (2021). Neuropeptide-S affects cognitive impairment and depression-like behavior on MPTP induced experimental mouse model of Parkinson’s disease. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(6). 3126–3135. 6 indexed citations
9.
Köksoy, Sadi, et al.. (2021). Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(11). 2259–2272. 9 indexed citations
10.
Özkan, Ayşe, Eren Öğüt, Fatoş Belgin Yıldırım, et al.. (2021). Protective mechanism of Syringic acid in an experimental model of Parkinson’s disease. Metabolic Brain Disease. 36(5). 1003–1014. 38 indexed citations
11.
Aycan, İlker Öngüç, et al.. (2021). Alleviation of prilocaine-induced epileptiform activity and cardiotoxicity by thymoquinone. DARU Journal of Pharmaceutical Sciences. 29(1). 85–99. 13 indexed citations
12.
Öğüt, Eren, Güven Akçay, Fatoş Belgin Yıldırım, Narin Derin, & Mutay Aslan. (2020). The influence of syringic acid treatment on total dopamine levels of the hippocampus and on cognitive behavioral skills. International Journal of Neuroscience. 132(9). 901–909. 17 indexed citations
13.
Tuğcu, Gökçen Dilşa, Filiz Özcan, Mutay Aslan, et al.. (2020). Plasma Ceramides and Sphingomyelins of Pediatric Patients Increase in Primary Ciliary Dyskinesia but Decrease in Cystic Fibrosis. Lipids. 55(3). 213–223. 6 indexed citations
14.
Aslan, Mutay, et al.. (2020). Organ function, sphingolipid levels and inflammation in tunicamycin induced endoplasmic reticulum stress in male rats. Human & Experimental Toxicology. 40(2). 259–273. 10 indexed citations
15.
Aslan, Mutay. (2020). Polyunsaturated Fatty Acid and Sphingolipid Measurements by Tandem Mass Spectrometry. Mini-Reviews in Organic Chemistry. 18(1). 3–10. 5 indexed citations
16.
Derin, Narin, et al.. (2018). The effects of sulfite on cPLA2, caspase-3, oxidative stress and locomotor activity in rats. Food and Chemical Toxicology. 123. 453–458. 15 indexed citations
17.
Aycan, İlker Öngüç, et al.. (2018). Diclofenac induced gastrointestinal and renal toxicity is alleviated by thymoquinone treatment. Food and Chemical Toxicology. 118. 795–804. 59 indexed citations
18.
Aslan, İbrahim, et al.. (2018). Early postoperative changes of sphingomyelins and ceramides after laparoscopic sleeve gastrectomy. Lipids in Health and Disease. 17(1). 269–269. 18 indexed citations
19.
Aslan, Mutay, et al.. (2018). Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients. Lipids. 53(3). 313–322. 16 indexed citations
20.
Aslan, Mutay, et al.. (2017). Effect of tauroursodeoxycholic acid on PUFA levels and inflammation in an animal and cell model of hepatic endoplasmic reticulum stress. Human & Experimental Toxicology. 37(8). 803–816. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiaki Tamaki Breakdown of academic impact, for papers by Neelam Khaper Breakdown of academic impact, for papers by Georg Kojda Breakdown of academic impact, for papers by Jung H. Suh Breakdown of academic impact, for papers by Paula Grammas Breakdown of academic impact, for papers by Lucia Ciccoli Breakdown of academic impact, for papers by Anna Nicolaou Breakdown of academic impact, for papers by Cláudia Penna Breakdown of academic impact, for papers by Seong‐Ho Koh Breakdown of academic impact, for papers by Jędrzej Antosiewicz
Rankless by CCL
2026